Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) is responsible for reviewing all research that involves the use of recombinant DNA in accord with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules and ensuring that the proposed activities comply with the federal regulations governing them.
-
IBC Office Hours
The IBC office hours are on every other Tuesday beginning February 11, 2025 from 10:00-11:00am.
- February: 11th and 25th, March: 11th and 25th, April: 8th and 22nd, May: 6th and 20th
- Office hours are through Zoom and available to CU users only (faculty, staff, and students).
- During the office hours sessions, you have an opportunity to meet privately with the IBC administrator. The sessions are not group sessions.
- A passcode is not required to join the Zoom sessions. You must login with your Clemson account to join the session.
If you are having issues logging into the Zoom sessions, try the following:
- Visit https://zoom.clemson.edu and login with your “clemson.edu” address, not a “g.clemson.edu” address.
- Download Zoom Workplace at https://zoom.us/download.
- Contact ITHELP@clemson.edu if you have issues accessing the Zoom web address, downloading Zoom Workplace, or logging into Zoom with your “clemson.edu” address.
- E-mail the IBC Office if you continue to have issues logging into the sessions.
-
What research does the CU IBC review and approve?
- Use of recombinant DNA or synthetic nucleic acid molecules
- Use of hazardous biological agents (BSL-2 and above)
- Use of select agents or toxins
- Use of nanomaterials with any of the above categories
See the IBC Resources Page for additional information.
-
How do I get started?
Access the General IBC FAQ for common questions.
-
How do I obtain approval to do my research?
All research requests and modifications are submitted using the InfoEd electronic submission system. Access InfoEd by clicking here or use menu above or buttons below.
- How are IBC protocols reviewed?
